HOYA Corporation (TYO:7741)
25,440
-185 (-0.72%)
Nov 7, 2025, 3:30 PM JST
HOYA Corporation Revenue
HOYA Corporation had revenue of 234.02B JPY in the quarter ending September 30, 2025, with 9.02% growth. This brings the company's revenue in the last twelve months to 892.50B, up 9.81% year-over-year. In the fiscal year ending March 31, 2025, HOYA Corporation had annual revenue of 866.03B with 13.56% growth.
Revenue (ttm)
892.50B
Revenue Growth
+9.81%
P/S Ratio
9.70
Revenue / Employee
23.54M
Employees
37,909
Market Cap
8.66T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 866.03B | 103.42B | 13.56% |
| Mar 31, 2024 | 762.61B | 39.03B | 5.39% |
| Mar 31, 2023 | 723.58B | 62.12B | 9.39% |
| Mar 31, 2022 | 661.47B | 113.55B | 20.72% |
| Mar 31, 2021 | 547.92B | -28.63B | -4.96% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.04T |
| Olympus | 969.02B |
| Eisai | 804.39B |